1. Home
  2. FTAIM vs KTTA Comparison

FTAIM vs KTTA Comparison

Compare FTAIM & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FTAIM

FTAI Aviation Ltd. 9.500% Fixed-Rate Reset Series D Cumulative Perpetual Redeemable Preferred Shares

N/A

Current Price

$27.12

Market Cap

0.0

Sector

Industrials

ML Signal

N/A

Logo Pasithea Therapeutics Corp.

KTTA

Pasithea Therapeutics Corp.

HOLD

Current Price

$0.52

Market Cap

18.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTAIM
KTTA
Founded
N/A
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Misc Corporate Leasing Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
18.1M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
FTAIM
KTTA
Price
$27.12
$0.52
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
1.3K
214.9K
Earning Date
N/A
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
1537.50
77.07
EPS
2.42
N/A
Revenue
$2,507,409,000.00
$486,559.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$11.20
N/A
Revenue Growth
44.53
3130.37
52 Week Low
$26.31
$0.28
52 Week High
$27.81
$2.06

Technical Indicators

Market Signals
Indicator
FTAIM
KTTA
Relative Strength Index (RSI) 39.47 47.80
Support Level $26.85 $0.48
Resistance Level $27.39 $0.52
Average True Range (ATR) 0.08 0.04
MACD -0.01 -0.01
Stochastic Oscillator 22.50 34.21

Price Performance

Historical Comparison
FTAIM
KTTA

About FTAIM FTAI Aviation Ltd. 9.500% Fixed-Rate Reset Series D Cumulative Perpetual Redeemable Preferred Shares

FTAI Aviation Ltd is an independent engine maintenance platform focused on the CFM56-5B, CFM56-7B, and V2500 aircraft engines, which power the 737NG and A320ceo aircraft. The company repairs and rebuilds engines in its maintenance facilities and with joint venture partners, and sells or leases engines through its proprietary Maintenance, Repair and Exchange (MRE) model under the Aerospace Products segment, which earns maximum revenue from North America and develops, repairs/refurbishes, and sells aircraft engines and aftermarket components. It also operates an Aviation Leasing segment, owning and managing a portfolio of on- and off-lease aircraft and engines, including engine transfers for rebuilding and sales.

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.

Share on Social Networks: